nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—forebrain—Alzheimer's disease	0.0177	0.0928	CbGeAlD
Isoprenaline—PIK3R3—telencephalon—Alzheimer's disease	0.011	0.0579	CbGeAlD
Isoprenaline—PIK3R2—nervous system—Alzheimer's disease	0.00959	0.0504	CbGeAlD
Isoprenaline—PIK3R1—telencephalon—Alzheimer's disease	0.00942	0.0494	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—Alzheimer's disease	0.00923	0.0485	CbGeAlD
Isoprenaline—PIK3R2—cerebellum—Alzheimer's disease	0.00902	0.0474	CbGeAlD
Isoprenaline—ADRBK1—embryo—Alzheimer's disease	0.00801	0.0421	CbGeAlD
Isoprenaline—MAPK1—embryo—Alzheimer's disease	0.00789	0.0415	CbGeAlD
Isoprenaline—PIK3R2—brain—Alzheimer's disease	0.00733	0.0385	CbGeAlD
Isoprenaline—ADRBK1—forebrain—Alzheimer's disease	0.00708	0.0372	CbGeAlD
Isoprenaline—MAPK1—forebrain—Alzheimer's disease	0.00698	0.0367	CbGeAlD
Isoprenaline—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.00673	0.0342	CcSEcCtD
Isoprenaline—ADRBK1—telencephalon—Alzheimer's disease	0.00651	0.0342	CbGeAlD
Isoprenaline—PIK3R3—nervous system—Alzheimer's disease	0.00651	0.0342	CbGeAlD
Isoprenaline—MAPK1—telencephalon—Alzheimer's disease	0.00642	0.0337	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—Alzheimer's disease	0.00627	0.0329	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—Alzheimer's disease	0.00612	0.0322	CbGeAlD
Isoprenaline—Pallor—Memantine—Alzheimer's disease	0.00601	0.0305	CcSEcCtD
Isoprenaline—Pallor—Rivastigmine—Alzheimer's disease	0.00588	0.0298	CcSEcCtD
Isoprenaline—PIK3R1—cerebellum—Alzheimer's disease	0.00523	0.0275	CbGeAlD
Isoprenaline—PIK3R3—brain—Alzheimer's disease	0.00497	0.0261	CbGeAlD
Isoprenaline—Pulmonary oedema—Memantine—Alzheimer's disease	0.00443	0.0225	CcSEcCtD
Isoprenaline—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00434	0.022	CcSEcCtD
Isoprenaline—PIK3R1—brain—Alzheimer's disease	0.00425	0.0223	CbGeAlD
Isoprenaline—Masoprocol—IGF1R—Alzheimer's disease	0.00397	0.389	CrCbGaD
Isoprenaline—ADRBK1—nervous system—Alzheimer's disease	0.00385	0.0202	CbGeAlD
Isoprenaline—MAPK1—nervous system—Alzheimer's disease	0.00379	0.0199	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—Alzheimer's disease	0.0037	0.0194	CbGeAlD
Isoprenaline—MAPK1—central nervous system—Alzheimer's disease	0.00365	0.0192	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—Alzheimer's disease	0.00362	0.019	CbGeAlD
Isoprenaline—MAPK1—cerebellum—Alzheimer's disease	0.00357	0.0187	CbGeAlD
Isoprenaline—Cardiac arrest—Memantine—Alzheimer's disease	0.00344	0.0175	CcSEcCtD
Isoprenaline—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00336	0.0171	CcSEcCtD
Isoprenaline—Angina pectoris—Donepezil—Alzheimer's disease	0.00335	0.017	CcSEcCtD
Isoprenaline—Flushing—Galantamine—Alzheimer's disease	0.0033	0.0167	CcSEcCtD
Isoprenaline—Arrhythmia—Galantamine—Alzheimer's disease	0.00317	0.0161	CcSEcCtD
Isoprenaline—Bronchospasm—Memantine—Alzheimer's disease	0.00307	0.0156	CcSEcCtD
Isoprenaline—Angina pectoris—Memantine—Alzheimer's disease	0.00304	0.0155	CcSEcCtD
Isoprenaline—Tension—Galantamine—Alzheimer's disease	0.00304	0.0154	CcSEcCtD
Isoprenaline—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00301	0.0153	CcSEcCtD
Isoprenaline—Nervousness—Galantamine—Alzheimer's disease	0.003	0.0153	CcSEcCtD
Isoprenaline—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00298	0.0151	CcSEcCtD
Isoprenaline—ADRB1—forebrain—Alzheimer's disease	0.00296	0.0156	CbGeAlD
Isoprenaline—Sweating—Donepezil—Alzheimer's disease	0.00294	0.0149	CcSEcCtD
Isoprenaline—ADRBK1—brain—Alzheimer's disease	0.00294	0.0154	CbGeAlD
Isoprenaline—Vision blurred—Galantamine—Alzheimer's disease	0.00291	0.0148	CcSEcCtD
Isoprenaline—Tremor—Galantamine—Alzheimer's disease	0.0029	0.0147	CcSEcCtD
Isoprenaline—MAPK1—brain—Alzheimer's disease	0.0029	0.0152	CbGeAlD
Isoprenaline—Vertigo—Galantamine—Alzheimer's disease	0.00278	0.0141	CcSEcCtD
Isoprenaline—Palpitations—Galantamine—Alzheimer's disease	0.00273	0.0139	CcSEcCtD
Isoprenaline—ADRB1—telencephalon—Alzheimer's disease	0.00273	0.0143	CbGeAlD
Isoprenaline—Convulsion—Galantamine—Alzheimer's disease	0.00268	0.0136	CcSEcCtD
Isoprenaline—Hypertension—Galantamine—Alzheimer's disease	0.00267	0.0136	CcSEcCtD
Isoprenaline—Sweating—Rivastigmine—Alzheimer's disease	0.00261	0.0133	CcSEcCtD
Isoprenaline—Tachycardia—Galantamine—Alzheimer's disease	0.00246	0.0125	CcSEcCtD
Isoprenaline—Arrhythmia—Donepezil—Alzheimer's disease	0.00246	0.0125	CcSEcCtD
Isoprenaline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00244	0.0124	CcSEcCtD
Isoprenaline—Hypotension—Galantamine—Alzheimer's disease	0.00236	0.012	CcSEcCtD
Isoprenaline—Tension—Donepezil—Alzheimer's disease	0.00235	0.0119	CcSEcCtD
Isoprenaline—Nervousness—Donepezil—Alzheimer's disease	0.00233	0.0118	CcSEcCtD
Isoprenaline—Flushing—Memantine—Alzheimer's disease	0.00232	0.0118	CcSEcCtD
Isoprenaline—Insomnia—Galantamine—Alzheimer's disease	0.00228	0.0116	CcSEcCtD
Isoprenaline—Flushing—Rivastigmine—Alzheimer's disease	0.00227	0.0115	CcSEcCtD
Isoprenaline—Vision blurred—Donepezil—Alzheimer's disease	0.00226	0.0115	CcSEcCtD
Isoprenaline—Tremor—Donepezil—Alzheimer's disease	0.00225	0.0114	CcSEcCtD
Isoprenaline—Arrhythmia—Memantine—Alzheimer's disease	0.00223	0.0113	CcSEcCtD
Isoprenaline—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00218	0.0111	CcSEcCtD
Isoprenaline—Vertigo—Donepezil—Alzheimer's disease	0.00215	0.0109	CcSEcCtD
Isoprenaline—Tension—Memantine—Alzheimer's disease	0.00214	0.0108	CcSEcCtD
Isoprenaline—Nervousness—Memantine—Alzheimer's disease	0.00211	0.0107	CcSEcCtD
Isoprenaline—Tension—Rivastigmine—Alzheimer's disease	0.00209	0.0106	CcSEcCtD
Isoprenaline—Convulsion—Donepezil—Alzheimer's disease	0.00208	0.0105	CcSEcCtD
Isoprenaline—Hypertension—Donepezil—Alzheimer's disease	0.00207	0.0105	CcSEcCtD
Isoprenaline—Nervousness—Rivastigmine—Alzheimer's disease	0.00207	0.0105	CcSEcCtD
Isoprenaline—Vision blurred—Memantine—Alzheimer's disease	0.00205	0.0104	CcSEcCtD
Isoprenaline—Tremor—Memantine—Alzheimer's disease	0.00204	0.0104	CcSEcCtD
Isoprenaline—Vision blurred—Rivastigmine—Alzheimer's disease	0.00201	0.0102	CcSEcCtD
Isoprenaline—Tremor—Rivastigmine—Alzheimer's disease	0.00199	0.0101	CcSEcCtD
Isoprenaline—Vertigo—Memantine—Alzheimer's disease	0.00196	0.00993	CcSEcCtD
Isoprenaline—Palpitations—Memantine—Alzheimer's disease	0.00192	0.00977	CcSEcCtD
Isoprenaline—Vertigo—Rivastigmine—Alzheimer's disease	0.00191	0.00971	CcSEcCtD
Isoprenaline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00189	0.0096	CcSEcCtD
Isoprenaline—Convulsion—Memantine—Alzheimer's disease	0.00189	0.00958	CcSEcCtD
Isoprenaline—Palpitations—Rivastigmine—Alzheimer's disease	0.00188	0.00955	CcSEcCtD
Isoprenaline—Hypertension—Memantine—Alzheimer's disease	0.00188	0.00954	CcSEcCtD
Isoprenaline—Convulsion—Rivastigmine—Alzheimer's disease	0.00184	0.00937	CcSEcCtD
Isoprenaline—Hypertension—Rivastigmine—Alzheimer's disease	0.00184	0.00933	CcSEcCtD
Isoprenaline—Hypotension—Donepezil—Alzheimer's disease	0.00183	0.00928	CcSEcCtD
Isoprenaline—Asthenia—Galantamine—Alzheimer's disease	0.00181	0.0092	CcSEcCtD
Isoprenaline—Insomnia—Donepezil—Alzheimer's disease	0.00177	0.00898	CcSEcCtD
Isoprenaline—Dyspnoea—Donepezil—Alzheimer's disease	0.00174	0.00886	CcSEcCtD
Isoprenaline—Tachycardia—Memantine—Alzheimer's disease	0.00173	0.0088	CcSEcCtD
Isoprenaline—Hyperhidrosis—Memantine—Alzheimer's disease	0.00172	0.00872	CcSEcCtD
Isoprenaline—Tachycardia—Rivastigmine—Alzheimer's disease	0.0017	0.00861	CcSEcCtD
Isoprenaline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00168	0.00853	CcSEcCtD
Isoprenaline—Dizziness—Galantamine—Alzheimer's disease	0.00167	0.00848	CcSEcCtD
Isoprenaline—Hypotension—Memantine—Alzheimer's disease	0.00166	0.00843	CcSEcCtD
Isoprenaline—Hypotension—Rivastigmine—Alzheimer's disease	0.00162	0.00825	CcSEcCtD
Isoprenaline—ADRB1—nervous system—Alzheimer's disease	0.00161	0.00845	CbGeAlD
Isoprenaline—Insomnia—Memantine—Alzheimer's disease	0.00161	0.00816	CcSEcCtD
Isoprenaline—Dyspnoea—Memantine—Alzheimer's disease	0.00158	0.00804	CcSEcCtD
Isoprenaline—Headache—Galantamine—Alzheimer's disease	0.00158	0.00803	CcSEcCtD
Isoprenaline—Insomnia—Rivastigmine—Alzheimer's disease	0.00157	0.00798	CcSEcCtD
Isoprenaline—Terbutaline—BCHE—Alzheimer's disease	0.00157	0.154	CrCbGaD
Isoprenaline—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00155	0.00787	CcSEcCtD
Isoprenaline—ADRB1—central nervous system—Alzheimer's disease	0.00155	0.00813	CbGeAlD
Isoprenaline—Nausea—Galantamine—Alzheimer's disease	0.0015	0.00761	CcSEcCtD
Isoprenaline—Asthenia—Donepezil—Alzheimer's disease	0.0014	0.00713	CcSEcCtD
Isoprenaline—Dizziness—Donepezil—Alzheimer's disease	0.00129	0.00657	CcSEcCtD
Isoprenaline—Asthenia—Memantine—Alzheimer's disease	0.00127	0.00647	CcSEcCtD
Isoprenaline—Asthenia—Rivastigmine—Alzheimer's disease	0.00125	0.00633	CcSEcCtD
Isoprenaline—ADRB1—brain—Alzheimer's disease	0.00123	0.00646	CbGeAlD
Isoprenaline—Headache—Donepezil—Alzheimer's disease	0.00123	0.00622	CcSEcCtD
Isoprenaline—Dizziness—Memantine—Alzheimer's disease	0.00117	0.00596	CcSEcCtD
Isoprenaline—Nausea—Donepezil—Alzheimer's disease	0.00116	0.0059	CcSEcCtD
Isoprenaline—Dizziness—Rivastigmine—Alzheimer's disease	0.00115	0.00584	CcSEcCtD
Isoprenaline—Headache—Memantine—Alzheimer's disease	0.00111	0.00565	CcSEcCtD
Isoprenaline—Headache—Rivastigmine—Alzheimer's disease	0.00109	0.00553	CcSEcCtD
Isoprenaline—Nausea—Memantine—Alzheimer's disease	0.00106	0.00536	CcSEcCtD
Isoprenaline—CYP1A1—nervous system—Alzheimer's disease	0.00104	0.00545	CbGeAlD
Isoprenaline—Nausea—Rivastigmine—Alzheimer's disease	0.00103	0.00524	CcSEcCtD
Isoprenaline—CYP1A1—central nervous system—Alzheimer's disease	0.000999	0.00525	CbGeAlD
Isoprenaline—Dopamine—MAOB—Alzheimer's disease	0.000933	0.0913	CrCbGaD
Isoprenaline—CYP1A1—brain—Alzheimer's disease	0.000793	0.00416	CbGeAlD
Isoprenaline—Arformoterol—CYP2D6—Alzheimer's disease	0.00064	0.0626	CrCbGaD
Isoprenaline—Formoterol—CYP2D6—Alzheimer's disease	0.00064	0.0626	CrCbGaD
Isoprenaline—Epinephrine—TNF—Alzheimer's disease	0.000511	0.05	CrCbGaD
Isoprenaline—Labetalol—CYP2D6—Alzheimer's disease	0.000468	0.0458	CrCbGaD
Isoprenaline—Pindolol—CYP2D6—Alzheimer's disease	0.000449	0.0439	CrCbGaD
Isoprenaline—Dopamine—SLC6A4—Alzheimer's disease	0.000422	0.0413	CrCbGaD
Isoprenaline—L-DOPA—CYP2D6—Alzheimer's disease	0.000319	0.0312	CrCbGaD
Isoprenaline—Dopamine—CYP2D6—Alzheimer's disease	0.000296	0.029	CrCbGaD
Isoprenaline—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.38e-05	2.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ESR1—Alzheimer's disease	1.37e-05	2.28e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—Alzheimer's disease	1.36e-05	2.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—F2—Alzheimer's disease	1.36e-05	2.25e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.35e-05	2.25e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ESR1—Alzheimer's disease	1.34e-05	2.22e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.33e-05	2.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOS3—Alzheimer's disease	1.33e-05	2.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.33e-05	2.2e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—F2—Alzheimer's disease	1.32e-05	2.2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—S100B—Alzheimer's disease	1.32e-05	2.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—AKT1—Alzheimer's disease	1.32e-05	2.18e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOS3—Alzheimer's disease	1.31e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—GSK3B—Alzheimer's disease	1.31e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.31e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.3e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS2—Alzheimer's disease	1.3e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MAPK8—Alzheimer's disease	1.3e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CREB1—Alzheimer's disease	1.3e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.3e-05	2.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—NOS3—Alzheimer's disease	1.29e-05	2.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOTCH1—Alzheimer's disease	1.29e-05	2.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—Alzheimer's disease	1.29e-05	2.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.28e-05	2.12e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.27e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—AKT1—Alzheimer's disease	1.26e-05	2.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF2—Alzheimer's disease	1.26e-05	2.09e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TGFB1—Alzheimer's disease	1.26e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—GSK3B—Alzheimer's disease	1.25e-05	2.07e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ACHE—Alzheimer's disease	1.24e-05	2.05e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TGFB1—Alzheimer's disease	1.24e-05	2.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CREB1—Alzheimer's disease	1.24e-05	2.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—INS—Alzheimer's disease	1.23e-05	2.04e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—INPP5D—Alzheimer's disease	1.22e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.22e-05	2.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1R—Alzheimer's disease	1.22e-05	2.02e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—GSK3B—Alzheimer's disease	1.22e-05	2.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.21e-05	2.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—GSK3B—Alzheimer's disease	1.21e-05	2.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL2—Alzheimer's disease	1.21e-05	2.01e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CREB1—Alzheimer's disease	1.21e-05	2e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-05	2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CREB1—Alzheimer's disease	1.2e-05	1.99e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—INS—Alzheimer's disease	1.2e-05	1.99e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.19e-05	1.98e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—INS—Alzheimer's disease	1.19e-05	1.98e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.19e-05	1.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IGF1—Alzheimer's disease	1.19e-05	1.97e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—Alzheimer's disease	1.19e-05	1.97e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—AKT1—Alzheimer's disease	1.19e-05	1.97e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.19e-05	1.97e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.19e-05	1.97e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL2—Alzheimer's disease	1.18e-05	1.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—Alzheimer's disease	1.18e-05	1.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—Alzheimer's disease	1.18e-05	1.95e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LPL—Alzheimer's disease	1.17e-05	1.94e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.17e-05	1.93e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IGF1—Alzheimer's disease	1.16e-05	1.93e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.16e-05	1.93e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS1—Alzheimer's disease	1.16e-05	1.93e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ENO1—Alzheimer's disease	1.16e-05	1.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MEF2C—Alzheimer's disease	1.16e-05	1.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.14e-05	1.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	1.14e-05	1.89e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PRKCG—Alzheimer's disease	1.13e-05	1.88e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CASP3—Alzheimer's disease	1.13e-05	1.87e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.13e-05	1.87e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.12e-05	1.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—Alzheimer's disease	1.12e-05	1.86e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CASP3—Alzheimer's disease	1.11e-05	1.85e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—Alzheimer's disease	1.11e-05	1.84e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—Alzheimer's disease	1.1e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NGF—Alzheimer's disease	1.1e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1.1e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—Alzheimer's disease	1.1e-05	1.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—AKT1—Alzheimer's disease	1.1e-05	1.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—BCL2—Alzheimer's disease	1.09e-05	1.81e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—BCHE—Alzheimer's disease	1.08e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—Alzheimer's disease	1.08e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—Alzheimer's disease	1.07e-05	1.78e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.07e-05	1.78e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—Alzheimer's disease	1.05e-05	1.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2A—Alzheimer's disease	1.05e-05	1.75e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.05e-05	1.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—Alzheimer's disease	1.05e-05	1.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAPK8—Alzheimer's disease	1.04e-05	1.72e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	1.04e-05	1.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—AKT1—Alzheimer's disease	1.03e-05	1.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—Alzheimer's disease	1.02e-05	1.7e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK8—Alzheimer's disease	1.02e-05	1.7e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—Alzheimer's disease	1.02e-05	1.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—Alzheimer's disease	1.02e-05	1.69e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	1.02e-05	1.69e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	1.01e-05	1.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—Alzheimer's disease	1.01e-05	1.68e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—Alzheimer's disease	1.01e-05	1.68e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.98e-06	1.66e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	9.94e-06	1.65e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—Alzheimer's disease	9.93e-06	1.65e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	9.86e-06	1.64e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	9.85e-06	1.64e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CALM1—Alzheimer's disease	9.81e-06	1.63e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—Alzheimer's disease	9.78e-06	1.62e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—Alzheimer's disease	9.78e-06	1.62e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	9.72e-06	1.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—Alzheimer's disease	9.69e-06	1.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CAV1—Alzheimer's disease	9.69e-06	1.61e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	9.67e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—Alzheimer's disease	9.64e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	9.64e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—Alzheimer's disease	9.58e-06	1.59e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—Alzheimer's disease	9.57e-06	1.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—Alzheimer's disease	9.46e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—Alzheimer's disease	9.46e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	9.45e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—Alzheimer's disease	9.44e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	9.42e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ESR1—Alzheimer's disease	9.33e-06	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—Alzheimer's disease	9.32e-06	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—Alzheimer's disease	9.31e-06	1.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—Alzheimer's disease	9.23e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—F2—Alzheimer's disease	9.22e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	9.21e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—Alzheimer's disease	9.17e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	9.16e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP3—Alzheimer's disease	9.15e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—Alzheimer's disease	9.09e-06	1.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—Alzheimer's disease	9.08e-06	1.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOTCH1—Alzheimer's disease	9.02e-06	1.5e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—Alzheimer's disease	9.01e-06	1.5e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	8.96e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	8.96e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—Alzheimer's disease	8.94e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP3—Alzheimer's disease	8.93e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—Alzheimer's disease	8.87e-06	1.47e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK8—Alzheimer's disease	8.84e-06	1.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—Alzheimer's disease	8.79e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	8.77e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—Alzheimer's disease	8.73e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—Alzheimer's disease	8.66e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—Alzheimer's disease	8.6e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	8.5e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GSK3B—Alzheimer's disease	8.47e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	8.46e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK8—Alzheimer's disease	8.41e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CREB1—Alzheimer's disease	8.4e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—Alzheimer's disease	8.39e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	8.36e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—INS—Alzheimer's disease	8.35e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	8.33e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	8.33e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—Alzheimer's disease	8.31e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—Alzheimer's disease	8.3e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	8.26e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—Alzheimer's disease	8.22e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK8—Alzheimer's disease	8.21e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—Alzheimer's disease	8.18e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	8.18e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	8.15e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	8.15e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1—Alzheimer's disease	8.08e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	8.08e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	7.96e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—F2—Alzheimer's disease	7.86e-06	1.3e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	7.78e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—Alzheimer's disease	7.76e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—LPL—Alzheimer's disease	7.74e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.69e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—F2—Alzheimer's disease	7.69e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—Alzheimer's disease	7.67e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—Alzheimer's disease	7.67e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—Alzheimer's disease	7.66e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—Alzheimer's disease	7.58e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.52e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—Alzheimer's disease	7.32e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—Alzheimer's disease	7.31e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—Alzheimer's disease	7.24e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	7.22e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	7.16e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—Alzheimer's disease	7.13e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—Alzheimer's disease	7.13e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—INS—Alzheimer's disease	7.12e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—Alzheimer's disease	7.07e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	7.06e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	7e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	7e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	6.97e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—INS—Alzheimer's disease	6.96e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—Alzheimer's disease	6.95e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—Alzheimer's disease	6.92e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	6.89e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	6.85e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	6.74e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—Alzheimer's disease	6.63e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—Alzheimer's disease	6.53e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CALM1—Alzheimer's disease	6.51e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—Alzheimer's disease	6.49e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAV1—Alzheimer's disease	6.43e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	6.24e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—Alzheimer's disease	6.22e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—Alzheimer's disease	6.18e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—Alzheimer's disease	6.11e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	6.11e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—Alzheimer's disease	6.02e-06	1e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—Alzheimer's disease	5.92e-06	9.83e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—Alzheimer's disease	5.87e-06	9.74e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—Alzheimer's disease	5.73e-06	9.5e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK8—Alzheimer's disease	5.72e-06	9.49e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—Alzheimer's disease	5.7e-06	9.46e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARG—Alzheimer's disease	5.65e-06	9.38e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—Alzheimer's disease	5.64e-06	9.37e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—INS—Alzheimer's disease	5.54e-06	9.2e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—Alzheimer's disease	5.37e-06	8.91e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.35e-06	8.88e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	5.3e-06	8.8e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—Alzheimer's disease	5.28e-06	8.76e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	5.27e-06	8.74e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—Alzheimer's disease	5.24e-06	8.7e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.23e-06	8.69e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—Alzheimer's disease	5.21e-06	8.65e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—Alzheimer's disease	5.21e-06	8.65e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	5.18e-06	8.61e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	5.15e-06	8.55e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—Alzheimer's disease	4.95e-06	8.22e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	4.87e-06	8.09e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—Alzheimer's disease	4.86e-06	8.07e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	4.86e-06	8.06e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—Alzheimer's disease	4.84e-06	8.04e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—Alzheimer's disease	4.83e-06	8.03e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—Alzheimer's disease	4.81e-06	7.98e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	4.76e-06	7.91e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	4.75e-06	7.89e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	4.5e-06	7.47e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	4.44e-06	7.38e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	4.4e-06	7.3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	4.13e-06	6.85e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	4.04e-06	6.7e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—Alzheimer's disease	3.99e-06	6.62e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—Alzheimer's disease	3.65e-06	6.06e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3.4e-06	5.64e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—Alzheimer's disease	3.37e-06	5.59e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	3.32e-06	5.52e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	3.11e-06	5.16e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	3.04e-06	5.05e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.87e-06	4.76e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.81e-06	4.66e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—Alzheimer's disease	2.23e-06	3.71e-06	CbGpPWpGaD
